Cargando…

Long-term effectiveness and safety of lacosamide as adjunctive therapy in children and adolescents with refractory epilepsy: a real-world study

PURPOSE: The effectiveness and tolerability of lacosamide (LCM) among Chinese children and adolescents with refractory epilepsy has not yet been established. Therefore, the objective of this study was to assess the effectiveness and tolerability of LCM among children and adolescents with refractory...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Ting, Yu, Lu-hai, Zhang, Hui-lan, Yu, Jing, Feng, Jie, Wang, Ting-ting, Sun, Yan, Li, Hong-jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10199619/ https://www.ncbi.nlm.nih.gov/pubmed/37210552 http://dx.doi.org/10.1186/s12887-023-04039-5

Ejemplares similares

Clinical Efficacy and Safety of Lacosamide as an Adjunctive Treatment in Adults With Refractory Epilepsy
por: Hou, Liyan, et al.
Publicado: (2021)

Safety of lacosamide in children with refractory partial epilepsy
por: Pasha, Ismail, et al.
Publicado: (2015)

Effectiveness and safety of Lacosamide therapy for children with focal epilepsy: a real world study
por: Yang, Chunsong, et al.
Publicado: (2023)

Impact of ABCB1 Polymorphisms on Lacosamide Serum Concentrations in Uygur Pediatric Patients With Epilepsy in China
por: Zhao, Ting, et al.
Publicado: (2022)

Genomic and clinical predictors of lacosamide response in refractory epilepsies
por: Heavin, Sinéad B., et al.
Publicado: (2019)

Long‐term safety and efficacy of lacosamide and controlled‐release carbamazepine monotherapy in patients with newly diagnosed epilepsy
por: Ben‐Menachem, Elinor, et al.
Publicado: (2019)

Impact of ABCC2 1249G>A and −24C>T Polymorphisms on Lacosamide Efficacy and Plasma Concentrations in Uygur Pediatric Patients With Epilepsy in China
por: Zhao, Ting, et al.
Publicado: (2023)

Evaluation of Cardiovascular Concerns of Intravenous Lacosamide Therapy in Epilepsy Patients
por: Lu, Yan-Ting, et al.
Publicado: (2022)

Efficacy of Lacosamide Add-on Therapy on Refractory Focal Epilepsies in Children and Adolescents: An Open-Label Clinical Trial
por: Mohammadi, Tayebeh, et al.
Publicado: (2023)

Efficacy of Lacosamide in a Patient with Refractory Generalized Epilepsy Based on Video Electroencephalography
por: Yamada, Hidetada, et al.
Publicado: (2021)

Lacosamide as the first add-on therapy in adult patients with focal epilepsy: A multicenter real-world study
por: Liu, Wenyu, et al.
Publicado: (2023)

Unmasking of myoclonus by lacosamide in generalized epilepsy
por: Birnbaum, Daniel, et al.
Publicado: (2016)

Lacosamide as treatment for partial epilepsy: mechanisms of action, pharmacology, effects, and safety
por: Kellinghaus, Christoph
Publicado: (2009)

Safety and efficacy of lacosamide versus phenytoin for refractory seizures in neurosurgical patients
por: Schaidle, Sarah, et al.
Publicado: (2021)

Efficacy and safety of levetiracetam as adjunctive therapy for refractory focal epilepsy
por: de MANREZA, Maria Luiza Giraldes, et al.
Publicado: (2021)

Adjunctive lacosamide treatment for adult focal-onset epilepsy: focus on comorbid intellectual/developmental disorders and differing responses
por: Doğan, Ebru Apaydın, et al.
Publicado: (2018)

Efficacy and tolerability of adjunctive lacosamide in pediatric patients with focal seizures
por: Farkas, Viktor, et al.
Publicado: (2019)

The effect of lacosamide on psychiatric comorbidities in patients with epilepsy
por: Hasegawa, Naoya, et al.
Publicado: (2020)

The therapeutic effects of lacosamide on epilepsy-associated comorbidities
por: He, Zihua, et al.
Publicado: (2023)

Long‐term safety and tolerability of lacosamide monotherapy in patients with epilepsy: Results from a multicenter, open‐label trial
por: Ben‐Menachem, Elinor, et al.
Publicado: (2021)

Refractory Ventricular Tachycardia and Seizures With Lacosamide Overdose
por: Marcellino, Chris, et al.
Publicado: (2022)

Safety and Tolerability of Lacosamide in Patients With Epilepsy: A Systematic Review and Meta-Analysis
por: Yang, Chunsong, et al.
Publicado: (2021)

Long-term efficacy and safety of adjunctive perampanel in pediatric patients aged 4–19 years with epilepsy: a real-world study
por: Youn, Song Ee, et al.
Publicado: (2023)

Lacosamide adjunctive therapy for partial-onset seizures: a meta-analysis
por: Sawh, Sonja C., et al.
Publicado: (2013)

Effectiveness and tolerability of lacosamide in children with drug resistant epilepsy
por: Driessen, J.T., et al.
Publicado: (2022)

Lacosamide may improve cognition in patients with focal epilepsy: EpiTrack to compare cognitive side effects of lacosamide and carbamazepine
por: Liguori, Claudio, et al.
Publicado: (2018)

Safety and tolerability of short‐term infusions of intravenous lacosamide in pediatric patients with epilepsy: An open‐label, phase 2/3 trial
por: Farkas, Mark Kristof, et al.
Publicado: (2023)

Profile of lacosamide and its role in the long-term treatment of epilepsy: a perspective from the updated NICE guideline
por: Nunes, Vanessa Delgado, et al.
Publicado: (2013)

Zonisamide Efficacy as Adjunctive Therapy in Children With Refractory Epilepsy
por: KARIMZADEH, Parvaneh, et al.
Publicado: (2013)

Efficacy and Safety of Lacosamide in Painful Diabetic Neuropathy
por: Ziegler, Dan, et al.
Publicado: (2010)

Ventricular tachycardia associated with lacosamide co-medication in drug-resistant epilepsy()
por: DeGiorgio, Andrew C., et al.
Publicado: (2012)

Lacosamide Precipitated Neutropenia in a Patient with Bipolar Disorder and Comorbid Epilepsy
por: Rao, Naren P., et al.
Publicado: (2018)

Effects of levetiracetam and lacosamide on therapeutic efficacy and neural function in patients with epilepsy
por: Liu, Airong, et al.
Publicado: (2020)

The efficacy and safety of adjunctive perampanel for the treatment of refractory focal‐onset seizures in patients with epilepsy: A meta‐analysis
por: Li, Yiming, et al.
Publicado: (2022)

Safety and tolerability of lacosamide monotherapy in the elderly: A subgroup analysis from lacosamide trials in diabetic neuropathic pain
por: Bainbridge, Jacquelyn, et al.
Publicado: (2017)

Efficacy and tolerability of lacosamide as adjunctive therapy in patients with focal-onset seizures: an observational, prospective study
por: Jin, Yang, et al.
Publicado: (2023)

Clinical Trial of Vigabatrin as Adjunctive Therapy in Children with Refractory Epilepsy
por: Taghdiri, Mohammad-Mahdi, et al.
Publicado: (2013)

Efficacy and safety of adjunctive lacosamide in the treatment of primary generalised tonic-clonic seizures: a double-blind, randomised, placebo-controlled trial
por: Vossler, David G, et al.
Publicado: (2020)

Time-to-Seizure Modeling of Lacosamide Used in Monotherapy in Patients with Newly Diagnosed Epilepsy
por: Lindauer, Andreas, et al.
Publicado: (2017)

Clinical stabilisation with lacosamide of mood disorder comorbid with PTSD and fronto-temporal epilepsy
por: Cuomo, Ilaria, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_tsqcb36id1atkg2uqae8n4n7rn